HEREDITARY ANGIOEDEMA
Clinical trials for HEREDITARY ANGIOEDEMA explained in plain language.
Never miss a new study
Get alerted when new HEREDITARY ANGIOEDEMA trials appear
Sign up with your email to follow new studies for HEREDITARY ANGIOEDEMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New monthly shot for rare swelling disorder tested for safety
Disease control Recruiting nowThis study is checking if it's safe for people with hereditary angioedema (HAE) to switch from their current preventive medication to a new monthly injection called garadacimab. It will involve about 30 people aged 12 and older who are already on a stable preventive treatment. Th…
Matched conditions: HEREDITARY ANGIOEDEMA
Phase: PHASE4 • Sponsor: CSL Behring • Aim: Disease control
Last updated Apr 04, 2026 03:05 UTC
-
New hope for kids with rare swelling disorder
Disease control AVAILABLEThis program provides early access to an experimental medication called sebetralstat for children ages 2-11 with hereditary angioedema (HAE). The medication is taken 'on-demand' to treat sudden swelling attacks when they occur. The goal is to see if this treatment can safely and …
Matched conditions: HEREDITARY ANGIOEDEMA
Sponsor: KalVista Pharmaceuticals, Ltd. • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
Silencing the gene: new trial aims to stop debilitating swelling attacks
Disease control Recruiting nowThis study is testing a new drug called ADX-324 to see if it can prevent the sudden, painful swelling attacks caused by hereditary angioedema (HAE). It will involve about 90 adults with HAE who will receive either the drug or a placebo. The main goal is to see if the drug reduces…
Matched conditions: HEREDITARY ANGIOEDEMA
Phase: PHASE3 • Sponsor: ADARx Pharmaceuticals, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Hospital launches major effort to map the mysteries of rare diseases
Knowledge-focused Recruiting nowThis study aims to create a single, large registry to collect information on many different rare diseases. It will enroll about 380 patients already being treated at the Hospital Italiano de Buenos Aires who have one of the listed rare conditions. The goal is to gather data to be…
Matched conditions: HEREDITARY ANGIOEDEMA
Sponsor: Hospital Italiano de Buenos Aires • Aim: Knowledge-focused
Last updated Mar 10, 2026 12:53 UTC